Table 3.
Regression of CMR trajectories on 3-year accumulative indices (Y1-Y3) of trauma and instability
| b | SE | β | 95% CI | P | |
|---|---|---|---|---|---|
| Outcome: BMI slope (kg/m2) | |||||
| Trauma | −0.04 | 0.05 | 0.22 | −0.14, 0.05 | .40 |
| Instability | 0.16 | 0.05 | −0.05 | 0.08, 0.25 | <.001 *** |
| Intervention 1 | −0.04 | 0.18 | −0.02 | −0.38, 0.31 | .82 |
| Intervention 2 | 0.16 | 0.17 | 0.06 | −0.17, 0.50 | .34 |
| Child agea | −0.01 | 0.01 | −0.05 | −0.03, 0.01 | .45 |
| Child sexb | −0.16 | 0.15 | −0.07 | −0.45, 0.13 | .27 |
| <High schoolc | −0.17 | 0.20 | −0.05 | −0.55, 0.21 | .38 |
| High school | −0.28 | 0.17 | −0.10 | −0.61, 0.05 | .10 |
| Baselined | 0.02 | 0.02 | 0.07 | −0.01, 0.05 | .22 |
| R2 = 0.08 | F(df) = 2.65 (9, 281) | <.001 *** | |||
| Outcome: HDL slope (mg/dL) | |||||
| Trauma | −0.14 | 0.11 | −0.07 | −0.08, 0.35 | .21 |
| Instability | −0.14 | 0.10 | −0.08 | −0.33, 0.06 | .18 |
| Intervention 1 | −0.16 | 0.39 | −0.03 | −0.92, 0.61 | .69 |
| Intervention 2 | −0.36 | 0.38 | −0.60 | −1.11, 0.39 | .35 |
| Child agea | −0.001 | 0.03 | −0.002 | −0.05, 0.05 | .97 |
| Child sexb | −1.21 | 0.32 | −0.21 | −1.85, −0.58 | <.001 *** |
| <High schoolc | −0.37 | 0.43 | −0.05 | −1.22, 0.48 | .39 |
| High school | 0.21 | 0.38 | 0.03 | −0.54, 0.95 | .59 |
| Child BMI | −0.04 | 0.03 | −0.07 | −0.10, 0.02 | .21 |
| Baselined | −0.10 | 0.02 | −0.39 | −0.12, −0.07 | <.001 *** |
| R2 = 0.20 | F(df) = 6.50 (10,272) | <.001 *** | |||
| Outcome: LDL slope (mg/dL) | |||||
| Trauma | −0.38 | 0.27 | −0.080 | −0.92, 0.15 | .16 |
| Instability | 0.19 | 0.25 | 0.043 | −0.31, 0.68 | .46 |
| Intervention 1 | 0.69 | 0.98 | 0.04 | −1.24, 2.62 | .48 |
| Intervention 2 | −0.24 | 0.96 | −0.01 | −2.14, 1.65 | .80 |
| Child agea | −0.04 | 0.06 | −0.04 | −0.17, 0.08 | .48 |
| Child sexb | −1.56 | 0.83 | −0.10 | −3.19, 0.07 | .06 |
| <High schoolc | −0.09 | 1.08 | −0.01 | −2.22, 2.04 | .93 |
| High school | −0.71 | 0.96 | −0.04 | −2.59, 1.18 | .46 |
| Child BMI | 0.14 | 0.08 | 0.10 | −0.01, 0.29 | .07 |
| Baselined | −0.11 | 0.02 | −0.38 | −0.15, −0.08 | <.001 *** |
| R2 = 0.19 | F(df) = 5.97 (10,272) | <.001 *** | |||
| Outcome: BP- systolic slope (%tile) | |||||
| Trauma | 0.18 | 0.30 | 0.03 | −0.41, 0.76 | .56 |
| Instability | 0.26 | 0.28 | 0.05 | −0.28, 0.81 | .35 |
| Intervention 1 | 0.42 | 1.07 | 0.02 | −1.69, 2.53 | .70 |
| Intervention 2 | 0.68 | 1.05 | 0.04 | −1.38, 2.74 | .52 |
| Child agea | −0.12 | 0.07 | −0.10 | −0.25, 0.01 | .08 |
| Child sexb | 2.27 | 0.90 | 0.14 | 0.50, 4.04 | .01 |
| <High schoolc | 0.45 | 1.20 | 0.02 | −1.90, 2.81 | .71 |
| High school | −1.06 | 1.03 | −0.06 | −3.08, 0.97 | .31 |
| Child BMI | 0.33 | 0.08 | 0.22 | 0.17, 0.49 | <.001 *** |
| Baselined | −0.16 | 0.02 | −0.47 | −0.19, −0.12 | <.001 *** |
| R2 = 0.24 | F(df) = 8.57 (10, 281) | <.001 *** | |||
| Outcome: BP- diastolic slope (%tile) | |||||
| Trauma | 0.13 | 0.23 | 0.03 | −0.33, 0.58 | .59 |
| Instability | 0.18 | 0.22 | 0.04 | −0.25, 0.60 | .42 |
| Intervention 1 | 0.59 | 0.85 | 0.04 | −1.08, 2.25 | .49 |
| Intervention 2 | −0.03 | 0.82 | −0.002 | −1.65, 1.59 | .97 |
| Child agea | −0.03 | 0.05 | −0.03 | −0.13, 0.08 | .60 |
| Child sexb | −1.24 | 0.71 | −0.09 | −2.63, 0.15 | .08 |
| <High schoolc | 0.71 | 0.94 | 0.04 | −1.15, 2.57 | .45 |
| High school | −1.15 | 0.81 | −0.08 | −2.75, 0.46 | .16 |
| Child BMI | 0.26 | 0.07 | 0.21 | 0.13, 0.39 | <.001 *** |
| Baselined | −0.18 | 0.02 | −0.54 | −0.21, −0.14 | <.001 *** |
| R2 = 0.28 | F(df) = 10−0.39 (10, 281) | <.001 *** | |||
| Outcome: triglycerides slope (mg/dL) | |||||
| Trauma | −0.01 | 0.01 | −0.05 | −0.03, 0.01 | .35 |
| Instability | −0.01 | 0.02 | −0.06 | −0.06, 0.04 | .68 |
| Intervention 1 | −2.05 | 1.85 | −0.06 | −5.69, 1.59 | .27 |
| Intervention 2 | −1.90 | 1.81 | −0.06 | −5.47, 1.67 | .30 |
| Child agea | 0.22 | 0.12 | 0.10 | −0.01, 0.46 | .06 |
| Child sexb | 4.48 | 1.54 | 0.14 | 1.44, 7.51 | .004 ** |
| <High schoolc | −0.52 | 2.06 | −0.01 | −4.57, 3.54 | .80 |
| High school | −0.18 | 1.80 | −0.01 | −3.72, 3.54 | .92 |
| Child BMI | 0.05 | 0.14 | 0.02 | −0.24, 0.33 | .76 |
| Baselined | −0.17 | 0.02 | −0.54 | −0.20, −0.14 | <.001 *** |
| R2 = 0.35 | F(df) = 14.15 (10, 272) | <.001 *** | |||
| Outcome: C-reactive protein slope (mg/dL) | |||||
| Trauma | −0.01 | 0.01 | −0.05 | −0.03, 0.01 | .35 |
| Instability | −0.01 | 0.02 | −0.06 | −0.06, 0.04 | .68 |
| Intervention 1 | −0.0001 | 0.02 | <0.001 | −0.04, 0.04 | .997 |
| Intervention 2 | 0.01 | 0.02 | <0.001 | −0.02, 0.05 | .52 |
| Child agea | −0.0001 | 0.001 | −0.01 | −0.002, 0.002 | .87 |
| Child sexb | −0.01 | 0.02 | −0.03 | −0.04, 0.02 | .56 |
| <High schoolc | 0.005 | 0.02 | −0.14 | −0.042, 0.042 | .81 |
| High school | −0.04 | 0.02 | −0.14 | −0.08, −0.01 | .01 * |
| Child BMI | 0.001 | 0.002 | 0.14 | 0.001, 0.007 | .02 * |
| Baselined | −0.18 | 0.03 | −0.44 | −0.23, −0.13 | <.001 *** |
| R2 = 0.20 | F(df) = 6.44 (10,272) | <.001 *** | |||
| Outcome: insulin sensitivity slope (mg/dL) | |||||
| Trauma | 0.001 | 0.05 | 0.002 | −0.09, 0.09 | .98 |
| Instability | −0.01 | 0.04 | −0.01 | −0.09, 0.07 | .85 |
| Intervention 1 | 0.11 | 0.16 | 0.04 | −0.21, 0.43 | .49 |
| Intervention 2 | 0.05 | 0.16 | 0.01 | −0.27, 0.36 | .77 |
| Child agea | −0.01 | 0.01 | −0.08 | −0.03, 0.01 | .18 |
| Child sexb | 0.12 | 0.14 | 0.08 | −0.08, 0.47 | .16 |
| <High schoolc | −0.16 | 0.18 | −0.05 | −0.52, 0.19 | .37 |
| High school | 0.01 | 0.16 | 0.003 | −0.30, 0.32 | .95 |
| Child BMI | 0.02 | 0.01 | 0.11 | −0.002, 0.05 | .07 |
| Baselined | −0.21 | 0.03 | −0.44 | −0.27, −0.16 | <.001 *** |
| R2 = 0.20 | F(df) = 6.66 (10,272) | <.001 *** |
Boldface indicates statistical significance
p < .05
p < .01
p < .001.
BMI = body mass index; CMR = cardiometabolic risk; HDL = high-density lipoprotein.
Child age measured in months.
Child sex reference group is male.
Education reference group is college education or higher.
Baseline indicator of the health outcome measured (e.g., baseline [Year 0] BMI when BMI was the outcome).